IMBA is part of the MAD-CoV 2 project and is funded with 1.1 Million Euros by the European Commission for developing antivirals against SARS-CoV-2.

The Vienna Science, Research and Technology Fund (WWTF) supports Viennese universities and research institutions with "COVID-19 Rapid Response Funding" - IMBA is involved in three projects to conduct potentially life-saving research and collect…

SARS-CoV-2, the virus causing coronavirus disease-19 (COVID-19), is spreading worldwide at a fast pace. In a concerted effort including researchers from IMBA – Institute of Molecular Biotechnology of the Austrian Academy of Sciences – a team of…

In a new study published in the Journal Science Advances, the Bell lab at IMBA reveals how multiple highly-conserved chromatin modifying complexes coordinate repression of differentiation genes safeguarding self-renewal and pluripotency of mouse…

A leading scientist in skin biology, Elaine Fuchs also chairs the Scientific Advisory Board (SAB) of IMBA. She is honored with the award for her research on tissue stem cells and their role in homeostasis, wound repair, inflammation and cancer.

In light of the current SARS-CoV-2 developments in Europe and worldwide, IMBA has decided to take the necessary steps in order to safeguard the health of all employees and contribute to flatten the curve.

Ábel Vertesy, Philipp Trepte and Ulrich Hohmann from IMBA – Institute of Molecular Biotechnology of the Austrian Academy of Sciences – are each awarded a prestigious Marie Skłodowska-Curie Individual Fellowship to conduct their research.

Renowned researcher and influential neuroscientist Wolf Singer, who is recognized for his studies on the development and functional organization of the mammalian cerebral cortex, delivered his lecture “The cerebral cortex: A substrate for…

An international consortium including Nicolas Rivron from the IMBA suggests potential applications and ethical guidelines to frame the research on human embryo models formed in a dish from stem cells.

Researchers from IMBA – Institute of Molecular Biotechnology of the Austrian Academy of Sciences – are granted funding for two projects from the Vienna Science and Technology Fund (WWTF), amounting to 700.000 Euro per project.